1.Construction and clinical application exploration of an artificial intelligence-based high-quality lung cancer surgery dataset
Xuhua HUANG ; Yunfeng NIE ; Liang SHEN ; Pengxu KONG ; Xin TAN ; Zihao LI ; Wang LV ; Min ZHOU ; Xudong LV ; Jian HU
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2026;33(05):717-727
Objective To construct a lung cancer surgery-oriented disease-specific database covering the entire perioperative care pathway, thereby improving the quality and usability of key surgical data elements. Methods Real-world clinical data were extracted from a single-center thoracic surgery department. A standardized data model was established based on the open electronic health record (openEHR) standard. Large language model (LLM), optical character recognition (OCR), and artificial intelligence (AI)-driven techniques were employed to extract, structure, and perform quality control on unstructured clinical narratives, imaging reports, and radiological data, with a focus on capturing surgically relevant perioperative indicator. Results A multimodal database comprising 19 917 patients was established, including 7 930 males and 11 987 females, with ages ranging from 15 to 97 (61.7±9.7) years. The database includes 582 structured data variables, textual report data corresponding to 69 clinical indicators, 13 000 pulmonary function test PDF reports, and chest CT imaging data from 16 884 patients. This database comprehensively covers major information relevant to surgical diagnosis and treatment of lung cancer, significantly improving the completeness and granularity of surgical detail data. Large language models (LLMs) and optical character recognition (OCR) technologies enhanced the efficiency of converting unstructured data into structured formats, while a multi-level manual verification process ensured data accuracy and traceability. The database supports real-world research including comparisons of surgical procedures, prediction of postoperative complications, prognosis assessment, and multimodal data association analyses.
2.Research progress on ocular accommodative function in the mechanism of axial elongation
Jiale DIAO ; Peng WU ; Jiantao REN ; Shuai SHENG ; Xudong HUANG
International Eye Science 2026;26(7):1210-1215
Accommodative dysfunction, particularly accommodative lag, acts as a core hub connecting near work activity to myopic axial elongation. This review thoroughly explores the multidimensional biological mechanisms by which accommodative function drives axial growth. In addition to the classic pathway where hyperopic defocus signals induce retinal-choroidal-scleral biochemical remodeling, two other mechanisms are highlighted: a biomechanical pathway involving direct mechanical traction on the equatorial sclera caused by sustained ciliary muscle contraction, and a neural pathway where abnormal accommodative micro fluctuations degrade retinal image quality, thereby triggering abnormal ocular growth. Based on these comprehensive mechanisms, this paper systematically analyzes the principles of pharmacological(atropine), optical(orthokeratology, defocus lenses), and vision therapy interventions. Myopia progression results from the integrated regulation of optical defocus, mechanical stress, and neural dynamics. Future myopia control should advance toward precise, personalized combination strategies tailored to individual accommodative and genetic profiles.
3.Current Research Status,Challenges,Differentiation and Treatment Strategies of Traditional Chinese Medicine for Gastroesophageal Reflux Disease
Fengyun WANG ; Mi LYU ; Bingduo ZHOU ; Beihua ZHANG ; Yi WANG ; Tingting XU ; Cong HE ; Xiaokang WANG ; Xin LIU ; Yang WANG ; Kaiyue HUANG ; Lusi XU ; Xudong TANG
Journal of Traditional Chinese Medicine 2026;67(4):392-396
This article systematically reviews the current research status as well as diagnosis and treatment strategies of traditional Chinese medicine (TCM) for gastroesophageal reflux disease (GERD). Studies demonstrate that TCM, based on the "disease-syndrome combination" approach, exhibits multi-target advantages in alleviating symptoms of various GERD subtypes, promoting mucosal repair, regulating emotions, and facilitating the reduction of western medication. To address clinical challenges such as symptom overlap and limited therapeutic efficacy, strategies have been proposed including "treating different diseases with the same method" and integrated regulation based on viscera correlation. Future efforts should focus on elucidating the mechanisms of compound prescriptions, promoting TCM drug development under the "three-combination" evaluation framework that integrates TCM theory, human experience and clinical trial evidence, and optimizing integrated traditional and western medicine models to enhance GERD management.
4.Current Status,Strategies and Prospects of Traditional Chinese Medicine Diagnosis and Treatment for Irritable Bowel Syndrome
Yandong WEN ; Zhi YANG ; Shaogang HUANG ; Zhongyu LI ; Xiangxue MA ; Qing XU ; Liqing DU ; Bochao YUAN ; Yibing TIAN ; Wentong GE ; Xiaofan ZHAO ; Chang LIU ; Xudong TANG
Journal of Traditional Chinese Medicine 2026;67(4):404-409
Irritable bowel syndrome (IBS) is a functional bowel disorder characterized primarily by abdominal pain and altered defecation habits. In recent years, traditional Chinese medicine (TCM) has made progress in multiple aspects of IBS research and treatment, including syndrome distribution, development of TCM formulas, clinical efficacy evaluation, external therapies, and psychosocial regulation. However, it still faces challenges such as over-reliance on symptomatic manifestations rather than biomarkers for diagnostic criteria, and the lack of high-quality evidence-based data supporting the efficacy of TCM formulas in treating IBS. This paper proposed that TCM diagnosis and treatment of IBS should adhere to the strategy of integrating the holistic concept with syndrome differentiation and treatment, combining TCM external therapies such as acupuncture, moxibustion and acupoint application), and emphasizing individualized diagnosis and treatment for psychosomatic abnormalities. Future research should integrate multi-omics technologies, artificial intelligence and other methods to deepen the understanding of the pathogenesis of IBS and the mechanisms of TCM formulas, so as to promote the standardization and internationalization of TCM in the diagnosis and treatment of IBS.
5.Syndrome Differentiation and Treatment of Diarrhea-Predominant Irritable Bowel Syndrome:Based on the Theory of "Zi Wu Liu Zhu (子午流注)"
Ting ZHENG ; Kaiyue HUANG ; Jiayan LI ; Fengyun WANG ; Xudong TANG ; Lin LYU
Journal of Traditional Chinese Medicine 2026;67(16):1728-1733
Based on the theory of Zi Wu Liu Zhu (子午流注, the ebb and flow of midnight and midday) and the clinical characteristics of diarrhea-predominant irritable bowel syndrome (IBS-D) that its symptoms mainly occur during chou (丑) period (01:00—03:00), mao (卯) period (5:00—7:00), and si (巳) period (9:00—11:00), this paper proposes a temporal pathogenesis chain of "liver constraint during chou period, intestinal stagnation during mao period, and spleen deficiency during si period". Within this chain, liver constraint serves as the initiating factor, and intestinal stagnation manifests as the branch, while spleen deficiency constitutes the root of the disease. Accordingly, a chronotherapeutic principle of "soothing the liver, regulating the intestines, and fortifying the spleen" is proposed, establishing a corresponding time-based syndrome differentiation and treatment system. During chou period, the treatment should focus on soothing the liver to relieve constraint and calming the mind to tranquilize the spirit, thereby blocking the mechanism of liver constraint overacting on the spleen. During mao period, the focus is regulating qi to resolve dampness and harmonizing the intestine to alleviate the branch symptoms of morning abdominal pain and diarrhea. During si period, the suggested method is fortifying the spleen and supplementing qi to drain dampness and stop diarrhea, thereby restoring the pivot of spleen-stomach transportation and transformation. These methods are complemented by strategies to optimize medication compliance, thereby providing a new chronotherapeutic approach for clinical diagnosis and treatment of IBS-D.
6.Applications of Digital Intelligence Technologies in Rare Disease Etiology Research
Yixuan GUO ; Yi GAO ; Hongrui ZHANG ; Anqi HUANG ; Yujie LI ; Xudong ZHANG ; Yaofang ZHANG ; Jian GUO ; Shuyang ZHANG
JOURNAL OF RARE DISEASES 2026;5(3):390-398
Digital intelligence technology is a comprehensive technical system with data as the key element and artificial intelligence as the core driving force. It provides innovative methodological support for addressing core bottlenecks in rare disease etiology research, including sample scarcity, high-dimensional datacomplexity, intricate pathogenic mechanisms, and challenges in causal validation. This paper systematically reviews the application pathways and current implementation of digital intelligence across four major stages of rare disease research, including etiological clue mining, causal inference, mechanism analysis, and clinical translation. Furthermore, it summarizes the technical strengths, existing limitations, and developmental challenges, aiming to inform optimization of the research paradigm and promote the sustainable advancement of rare disease research.
7.Advances in artificial intelligence for benign-malignant differentiation and risk-stratified management of pulmonary nodules
Xuhua HUANG ; Yiqing WANG ; Xudong LÜ ; ; Jianmin WU ; Ping WANG ; Wang LÜ ; ; Jian HU ; Luming WANG
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2026;33(10):1559-1572
With the increasing use of low-dose computed tomography (LDCT) in lung cancer screening and health examinations, the clinical goal of pulmonary nodule management has shifted from detecting nodules to identifying lesions that warrant intervention while avoiding overdiagnosis and overtreatment of low-risk disease. Artificial intelligence (AI) has consequently evolved from computer-aided detection and segmentation to benign-malignant differentiation, longitudinal growth assessment, invasiveness prediction, risk stratification, and closed-loop workflow support. This review outlines the developmental trajectory of AI for pulmonary nodules and summarizes advances in detection and segmentation, radiomics, end-to-end deep learning, longitudinal modeling, and multimodal integration across incidentally detected, screening-detected, subsolid, and multiple-nodule scenarios. Particular attention is given to real-world failure modes and their causes, including data and label bias, scanner- and protocol-related distribution shift, spectrum bias and overfitting in subsolid nodules, missed atypical lesions, automation bias, and management of discordance between AI outputs and guideline-based recommendations. Current evidence suggests that AI may improve detection efficiency and risk reclassification in selected settings; however, evidence regarding cross-population calibration, patient-relevant outcomes, cost-effectiveness, and post-deployment monitoring remains limited. AI should therefore be positioned as a human-in-the-loop adjunct within guideline-governed pathways, supported by scenario-specific validation, transparent reporting, interpretability and accountability, continuous performance auditing, and multidisciplinary decision-making.
8.A CYP80B enzyme from Stephania tetrandra enables the 3'-hydroxylation of N-methylcoclaurine and coclaurine in the biosynthesis of benzylisoquinoline alkaloids.
Yaoting LI ; Yuhan FENG ; Wan GUO ; Yu GAO ; Jiatao ZHANG ; Lu YANG ; Chun LEI ; Yun KANG ; Yaqin WANG ; Xudong QU ; Jianming HUANG
Chinese Journal of Natural Medicines (English Ed.) 2025;23(5):630-640
Benzylisoquinoline alkaloids (BIAs) are a structurally diverse group of plant metabolites renowned for their pharmacological properties. However, sustainable sources for these compounds remain limited. Consequently, researchers are focusing on elucidating BIA biosynthetic pathways and genes to explore alternative sources using synthetic biology approaches. CYP80B, a family of cytochrome P450 (CYP450) enzymes, plays a crucial role in BIA biosynthesis. Previously reported CYP80Bs are known to catalyze the 3'-hydroxylation of (S)-N-methylcoclaurine, with the N-methyl group essential for catalytic activity. In this study, we successfully cloned a full-length CYP80B gene (StCYP80B) from Stephania tetrandra (S. tetrandra) and identified its function using a yeast heterologous expression system. Both in vivo yeast feeding and in vitro enzyme analysis demonstrated that StCYP80B could catalyze N-methylcoclaurine and coclaurine into their respective 3'-hydroxylated products. Notably, StCYP80B exhibited an expanded substrate selectivity compared to previously reported wild-type CYP80Bs, as it did not require an N-methyl group for hydroxylase activity. Furthermore, StCYP80B displayed a clear preference for the (S)-configuration. Co-expression of StCYP80B with the CYP450 reductases (CPRs, StCPR1, and StCPR2), also cloned from S. tetrandra, significantly enhanced the catalytic activity towards (S)-coclaurine. Site-directed mutagenesis of StCYP80B revealed that the residue H205 is crucial for coclaurine catalysis. Additionally, StCYP80B exhibited tissue-specific expression in plants. This study provides new genetic resources for the biosynthesis of BIAs and further elucidates their synthetic pathway in natural plant systems.
Cytochrome P-450 Enzyme System/chemistry*
;
Benzylisoquinolines/chemistry*
;
Hydroxylation
;
Plant Proteins/chemistry*
;
Alkaloids/metabolism*
;
Stephania tetrandra/genetics*
9.Ileal injury secondary to percutaneous nephrolithotomy:a case report and literature review
Xudong LIU ; Qiang XU ; Jianbin YIN ; Shiyuan DUAN ; Hongtao HU ; Taichao SONG ; Shaoshun WEI ; Zaoming HUANG
Journal of Modern Urology 2025;30(7):603-606,封1
Objective To investigate the clinical characteristics,diagnosis and treatment of ileal injury secondary to percutaneous nephrolithotomy percutaneous nephrolithotomy(PCNL).Methods The diagnosis and treatment of a patient were reviewed,and relevant literature were retrieved.Results The patient was a 41-year-old male,who underwent stage PCNL(initial percutaneous nephrostomy,followed by secondary PCNL)due to right ureteral calculi with severe hydronephrosis.On postoperative day 1,he developed abdominal distension and pain.Abdominal X-ray revealed subdiaphragmatic free gas,and CT showed pelvic and abdominal fluid and gas accumulation,suggesting peritonitis due to intestinal perforation.Emergency exploratory laparotomy identified a 3 mm×3 mm ileal perforation approximately 30 cm from the ileocecal valve,which was repaired surgically.The patient recovered well and was discharged after one week,with no discomfort reported during a 6-month follow-up.Conclusion The clinical features of ileal injury secondary to PCNL include early postoperative abdominal distension,pain and peritonitis.Diagnosis relies on clinical manifestations,abdominal X-ray and CT,with surgical exploration if necessary.Conservative management under vigilant observation can be cautiously adopted for localized injuries,while surgical repair is required for peritonitis or failed conservative therapy.
10.The effect of anti-reflux sleeve gastrectomy and sleeve gastrectomy on the levels of adipokines and inflammation related cells
Chinese Journal of General Surgery 2025;40(4):262-267
Objective:To investigate the effects of anti-reflux sleeve gastrectomy and sleeve gastrectomy on circulating adipokines and inflammation related cell levels.Method:A retrospective cohort study was conducted to analyze the data of 45 obese patients undergoing laparoscopic sleeve gastrectomy plus fundoplication (LSGFD) and laparoscopic sleeve gastrectomy (LSG) at Xinjiang Uygur Autonomous Region People's Hospital from Apr to Sep 2023. Patients were followed-up for 6-month .Body weight, fasting plasma glucose (FPG), 2-hour postprandial glucose (2-h PG), GERD questionnaire score (GERD-Q), circulating leptin, adiponectin, peripheral white blood cell count (WBC), neutrophils (NE), lymphocytes (LY), and neutrophil-to-lymphocyte ratio (NLR) between two groups of patients before surgery and 6 months after surgery were conducted.Results:The operative times for the LSGFD group and the LSG group were 180 (105-240) minutes and 125 (85-180) minutes, respectively ( Z=-3.358, P<0.01). There were no statistically significant differences in intraoperative blood loss, total hospital stays, postoperative hospital stays, use of robotic assistance, or readmission within 30 days postoperatively (all P>0.05). Six months after LSG, patient's weight, BMI, 2-h PG decreased ( all P<0.05), Six months after LSGFD, patient's circulating leptin, peripheral blood WBC, NE, and NLR levels decreased ( Z=-3.808, -3.173, -3.435, -2.389, -3.173, all P<0.05). Six months after LSG, patient's circulating leptin, peripheral blood WBC, NE, and NLR levels decreased ( Z=-4.292, -3.606, -3.431, -2.220, -3.619, all P<0.05). Conclusion:LSGFD and LSG not only significantly reduce the weight of obese patients but also improve the levels of circulating adipokines and inflammatory status.

Result Analysis
Print
Save
E-mail